Physician scientists at 22 consortia, including investigators at the University of Alabama at Birmingham, will collaborate with representatives of 98 patient advocacy groups to advance clinical research and investigate new treatments for patients with rare diseases.

"I hope business leaders admire us for our contributions to the community by providing high quality patient care, taking care of those in need, supporting Cooper Green, and being involved in our community by supporting programs like the Health Academy," said Will Ferniany.

According to new research from the University of Alabama at Birmingham School of Public Health, states with primary texting laws on the books, which means that officers can pull over a driver simply for texting while driving, have seen an 11 percent drop in fatalities for young drivers ages 15 to 21.

"In about 60 percent of patients who had their [fallopian] tubes still intact, we were able to pick up tumor cells, or essentially tumor DNA, in the vaginal tract," said Dr. Charles Landen, who was at the University of Alabama at Birmingham at the time of the study.

Movi Medical, a local design firm that developed a new, state-of-the-art patient transport chair at the request of an executive at The University of Alabama at Birmingham (UAB) Health System, is winning orders for its chairs, winning national recognition for its design, developing other products and running a Kickstarter crowd-funding campaign.

“Since mapping the entire human genome, advances in the speed of high throughput sequencing and reductions in cost have given us the capacity to identify genetic abnormalities in a given cancer,” Edward Partridge, MD, Director of the UAB Comprehensive Cancer Center, said. “We’ve been collaborating with HudsonAlpha on the genomics of cancer for several years. The consortium formalizes the relationship under a core grant from the NIH, and gives us a structure to work together more productively.”

An assistant professor in The University of Alabama at Birmingham (UAB) School of Nursing is one of only 12 nursing educators in the United States to be selected for the Robert Wood Johnson Foundation Nurse Faculty Scholars program this year.

The growing field of young piano virtuosos coming to Birmingham gets a little more crowded Sunday, Oct. 12, when Eric Lu, a 16-year-old prize winner who entered the Curtis Institute of Music last year, opens the 2014-15 UAB Piano Series.

Jimmie Johnson, one of the 12 contenders for the 2014 Chase for the NASCAR Sprint Cup, will be on the UAB campus Wednesday to officiate the annual Gurney Derby, a traditional homecoming race for the school.

Concerns over Ebola are bringing more patients to physicians with questions. We reached out to a variety of experts to get their "talking points" and advice on what physicians should say when patients ask about Ebola.

The Nurse Faculty Scholar awards are given to junior nurse faculty who show strong promise as future leaders in academic nursing. Each scholar receives a three-year $350,000 award to pursue research, leadership training in all aspects of the faculty role, and mentoring from senior faculty at their institution.

Sponsored by the UAB National Alumni Society, this tradition recognizes outstanding male and female students who have demonstrated scholastic achievement, leadership, involvement and overall enthusiasm.

Soluble Therapeutics, a protein solubility company spun off from research at the University of Alabama at Birmingham, has acquired Seattle-based Dilyx Biotechnologies in a deal that will strengthen the ability of the company's flagship HSC technology.

Here are some questions and answers from our interview with TOS Fellow David B Allison, PhD, Distinguished Professor, Quetelet Endowed Professor of Public Health, Associate Dean for Science of the School of Public Health at the University of Alabama at Birmingham.

Dr. David Kimberlin, co-director of the UAB Division of Pediatric Infectious Diseases at Children's, said they don't know the neurological symptoms are linked to the virus, and if it was: "It would be very rare."

This catastrophic event prompted UAB public health expert Dr. Lisa McCormick to seek the answer to a very important question. “Since the tornado have you thought more about personal preparedness?” she asked.

The University of Alabama at Birmingham (UAB) School of Education has been awarded a seven-year, $49 million grant -- its largest ever -- to serve as the hub of GEAR UP Alabama, a federally funded program to help increase the number of low-income students in Alabama's poverty-plagued Black Belt that are prepared to attend college.

It's possible that some people were infected in the gap between the onset of symptoms and the patient's isolation at Texas Health Presbyterian, according to Craig Wilson, MD, of the University of Alabama at Birmingham.

women held only 27.5 percent of jobs nationally across science and engineering fields as of 2010, according to the National Science Foundation. And it doesn't get better as you dig into the data. In engineering, women make up 12.7 percent of the workforce. In healthcare, women make up 69.7 percent of medical and health services managers, but rarely attain chief executive positions.

From the quality of medical care to access to medical care to the ability to quickly quarantine infectious diseases, there are a lot of reasons the likelihood of an Ebola outbreak here in the U.S. is so small. But if someone exhibiting Ebola like symptoms did walk into UAB Hospital, doctors say they would be ready. Emergency rooms are always busy but with Ebola fears on everyone’s mind, the ER staff at UAB is ever vigilant.

Dr. Helen Krontiras doesn’t take lightly her role in helping women live through what can be the darkest times in their lives. And with the rapid advancements in breast cancer research and treatment, the co-director of the University of Alabama at Birmingham Breast Health Center says she thinks a more personalized approach to women’s healthcare is more important than ever.

Shin J. Oh, MD, Distinguished Professor Emeritus of Neurology, University of Alabama at Birmingham, School of Medicine, stated, "I am extremely pleased to see the results from the first ever Phase 3 controlled study in this LEMS patient population, which confirmed a positive treatment effect for Firdapse. When combined with the favorable safety profile, the results indicate that the drug should become the standard of care in treating LEMS patients once approved by the FDA."

GRADE investigators seek to enroll a cross-section of patients of any age, gender and ethnicity. The study will follow its participants for seven years and will provide them with complete diabetes care, as well as free supplies and medications, at no cost.